The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO

Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai Co.'s combo therapy was rejected by the FDA.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.